| Analysis of safety and efficacy of pegylated-interferon alpha-2a in hepatitis C virus positive hemodialysis patients: results from a large, multicenter audit. A Covic, ID Maftei, NG Mardare, F Ioniţă-Radu, C Totolici, L Tuţă, O Golea, ... Journal of Nephrology 19 (6), 794-801, 2006 | 75 | 2006 |
| Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study S Danese, JF Colombel, M Lukas, JP Gisbert, G d'Haens, B Hayee, ... The lancet Gastroenterology & hepatology 7 (2), 118-127, 2022 | 72 | 2022 |
| HCV genotype 1 is almost exclusively present in Romanian patients with chronic hepatitis C. M Grigorescu Journal of Gastrointestinal and Liver Diseases: JGLD 18 (1), 45-50, 2009 | 51 | 2009 |
| Targeting PI3K/AKT/mTOR signaling pathway in pancreatic cancer: from molecular to clinical aspects S Stanciu, F Ionita-Radu, C Stefani, D Miricescu, II Stanescu-Spinu, ... International Journal of Molecular Sciences 23 (17), 10132, 2022 | 50 | 2022 |
| Hematologic manifestations in celiac disease—a practical review DV Balaban, A Popp, F Ionita Radu, M Jinga Medicina 55 (7), 373, 2019 | 46 | 2019 |
| Therapeutic potential of interleukin‑15 in cancer G Isvoranu, M Surcel, AN Munteanu, OG Bratu, F Ionita‑Radu, MT Neagu, ... Experimental and therapeutic medicine 22 (1), 1-6, 2021 | 42 | 2021 |
| Laparoscopic sleeve gastrectomy and gastroesophageal reflux AL Popescu, F Ioniţa-Radu, M Jinga, AI Gavrilă, FA Săvulescu, ... Romanian Journal of Internal Medicine 56 (4), 227-232, 2018 | 34 | 2018 |
| Unfavorable influence of prematurity on the neonatal prognostic of small for gestational age fetuses N Turcan, RE Bohiltea, F Ionita‑Radu, F Furtunescu, D Navolan, ... Experimental and Therapeutic Medicine 20 (3), 2415-2422, 2020 | 33 | 2020 |
| Prediction of NAFLD occurrence in prediabetes patients CM Vesa, T Behl, S Nemeth, OG Bratu, CC Diaconu, RD Moleriu, ... Experimental and Therapeutic Medicine 20 (6), 1-1, 2020 | 27 | 2020 |
| Retroperitoneal tumors–treatment and prognosis of tumor recurrence OG Bratu, AI Cherciu, A Bumbu, S Lupu, DR Marcu, F Ionita Radu, ... Rev Chim 70 (1), 191-194, 2019 | 23 | 2019 |
| The role of alpha-1blockers in the medical expulsive therapy for ureteral calculi-a prospective controlled randomized study comparing tamusolin and silodosin D Georgescu, F Ionita-Radu, R Multescu, M Dragutescu, B Geavlete, ... Farmacia 63 (2), 184-188, 2015 | 20 | 2015 |
| Diagnostic challenges in gastrointestinal infections N Negrut, SA Khan, S Bungau, DC Zaha, CAR Anca, O Bratu, ... Rom J Mil Med 123, 83-90, 2020 | 19 | 2020 |
| Autonomic dysfunctions in multiple sclerosis: Challenges of clinical practice CA Sirbu, RM Mezei, C Falup‑Pecurariu, OG Bratu, AM Sirbu, ... Experimental and Therapeutic Medicine 20 (6), 1-1, 2020 | 17 | 2020 |
| Minimally invasive biopsy in retroperitoneal tumors RD Marcu, CC Diaconu, T Constantin, B Socea, F Ionita‑Radu, ... Experimental and Therapeutic Medicine 18 (6), 5016-5020, 2019 | 17 | 2019 |
| Vaccination in multiple sclerosis‑Challenging practices CA Sirbu, AA Florea, MC Ghinescu, A Docu‑Axelerad, AM Sirbu, OG Bratu, ... Experimental and Therapeutic Medicine 20 (6), 1-1, 2020 | 15 | 2020 |
| Influence of anti‑TNF therapy and homocysteine level on carotid intima‑media thickness in rheumatoid arthritis patients D Anghel, CA Sîrbu, EM Hoinoiu, OG Petrache, CF Pleșa, MM Negru, ... Experimental and Therapeutic Medicine 23 (1), 1-7, 2022 | 14 | 2022 |
| The impact of infection with hepatitis C virus on cardiovascular risk RA Iorga, N Bacalbasa, OG Bratu, FI Radu, CC Diaconu American journal of cardiovascular disease 10 (3), 201, 2020 | 14 | 2020 |
| Vascular involvement in primary retroperitoneal tumors DR Marcu, F Ionita-Radu, LD Iorga, M Manea, B Socea, I Scarneciu, ... Rev Chim 70, 445-448, 2019 | 14 | 2019 |
| Manometric changes of the esophagus in morbidly obese patients AL Popescu, RS Costache, DO Costache, VD Balaban, M Jinga, ... Experimental and Therapeutic Medicine 21 (6), 1-5, 2021 | 13 | 2021 |
| IL28B polymorphism--predictive factor of HCV infected genotype 1 individuals to treatment response and management of therapy. F Ioniţă-Radu, A Raşcanu, B Cheiab Romanian Journal of Internal Medicine= Revue Roumaine de Medecine Interne 49 …, 2011 | 13 | 2011 |
